Delivery Order SPE2DB22D1017-SPE2DB24FF1YB
- Not listed
- This federal contract award, valued at $14,625.76, was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The award is for the delivery of SHINGRIX VIAL KITS, a pharmaceutical product, with an ultimate completion date of April 26, 2024. The contract is a Delivery Order with a Firm Fixed Price pricing type. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that plays a critical role in...
- This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract, valued at $56,385.57, is for the delivery of SHINGRIX vial kits. This is a firm fixed-price delivery order contract with an ultimate completion date of September 27, 2023. The contract does not have a set-aside designation, indicating it was awarded through full and open competition. Amerisourcebergen Drug Corp is a major pharmaceutical...
- This federal contract award is a delivery order from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract, valued at $11,040.80, is for the delivery of SHINGRIX Vial Kits, a pharmaceutical product. The delivery order has a firm fixed price pricing type and a completion date of March 13, 2024. Amerisourcebergen Drug Corp, as a major pharmaceutical distributor, has a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $19,003.00 firm fixed-price delivery order is for "SHINGRIX VIAL KITS" and has a completion date of January 13, 2022. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order (SPE2DB22D2007|SPE2DB23FJ2HF) valued at $21,945.86 for the supply of SHINGRIX VIAL KITS. The contract was awarded by the Defense Logistics Agency (DLA), a defense agency, with a completion date of May 11, 2023. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that plays a critical role in supplying medical products to federal government agencies, particularly the...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $35,127.29 firm fixed-price delivery order is for the provision of SHINGRIX vaccine kits and has a completion date of May 7, 2024. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which maintains a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
- This federal contract award, valued at $98,746.77, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The award is a delivery order under an Indefinite Delivery Contract (IDC) held by Cencora, Inc. with the DLA Troop Support Medical, valued at up to $999,999,999.00 through November 2026. The contract covers the delivery of SHINGRIX VIAL KITS, a pharmaceutical product, to support military healthcare programs. The award has no set-aside...
- This federal contract award, valued at $10,878.70, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The award is for the delivery of SHINGRIX VIAL KITS, a pharmaceutical product, with a completion date of November 30, 2023. The contract is a firm-fixed-price delivery order, with no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., for the delivery of 4,562,126,804 units of SHINGRIX vial kits. The Firm Fixed Price delivery order, valued at $1,069.01, has a completion date of September 12, 2023. This award is not designated with a set-aside requirement, indicating open competition. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that plays a critical role in...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $14,252.25 contract provides the DLA with deliveries of SHINGRIX vial kits, a vaccine product. The award is a firm fixed-price delivery order and was not set aside for any specific business category. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that serves as a key supplier to various government agencies, particularly the Department...
- SPE2DB22D1017Indefinite Delivery Contract
- SPE2DB22D1017-SPE2DB24FF1YBDelivery Order
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract, valued at $15,548.69, is a delivery order for SHINGRIX vial kits. It has a period of performance through January 29, 2024 and utilizes a firm fixed price pricing type. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that serves as a key vendor for federal healthcare programs, particularly supporting the Department of Defense and Department of Veterans Affairs. The company holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999, which serves as the primary vehicle for delivering a comprehensive range of pharmaceutical products and medical supplies to DLA facilities worldwide. This delivery order contract appears to be part of that larger IDC arrangement. The contract award did not utilize any set-aside designations, indicating full and open competition.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $15.5k | 1/26/24 |